Naldemedine Tosylate

甲苯磺酸纳地美定

Report date: 2025/05/30 13:31:52
NME

Base Information

Drug NameNaldemedine Tosylate
Drug Alias NameNaldemedine tosilate纳地美定naldemedinum纳迪美定naldemedina +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor antagonists
TargetsMu opioid receptor
Therapy Area/IndicationsOpioid-Induced ConstipationConstipationGastrointestinal Diseases
Global Approved IndicationsOpioid-Induced ConstipationConstipation
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2017/03/23
Country/TerritoryMainland China(BOAO LECHENG)CzechiaBelgium +[25
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOpioid-Induced ConstipationConstipation
Inactive IndicationsGastrointestinal Diseases

Other Information

ATC CodeA06AH05